Assessing guideline adherence in patients with non-variceal upper gastrointestinal bleeding receiving antiplatelet and anticoagulant therapy

References

• Van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209–224.
   PubMed Web of Science ®Google Scholar
• Hearnshaw SA, Logan RF, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut. 2011;60(10):1327–1335.
   PubMed Web of Science ®Google Scholar
• Wuerth BA, Rockey DC. Changing epidemiology of upper gastrointestinal hemorrhage in the last decade: a nationwide analysis. Dig Dis Sci. 2018;63(5):1286–1293.
   PubMed Web of Science ®Google Scholar
• Lanas A, Dumonceau JM, Hunt RH, et al. Non-variceal upper gastrointestinal bleeding. Nat Rev Dis Primers. 2018;4(1):18020.
   PubMedGoogle Scholar
• Laine L. Clinical practice. Upper gastrointestinal bleeding due to a peptic ulcer. N Engl J Med. 2016;374(24):2367–2376.
   PubMedGoogle Scholar
• Sung JJ, Tsoi KK, Ma TK, et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol. 2010;105(1):84–89.
   PubMed Web of Science ®Google Scholar
• Crooks C, Card T, West J. Reductions in 28-day mortality following hospital admission for upper gastrointestinal hemorrhage. Gastroenterology. 2011;141(1):62–70.
   PubMed Web of Science ®Google Scholar
• Jairath V, Martel M, Logan RF, et al. Why do mortality rates for nonvariceal upper gastrointestinal bleeding differ around the world? A systematic review of cohort studies. Can J Gastroenterol. 2012;26(8):537–543.
   PubMed Web of Science ®Google Scholar
• Masclee GM, Valkhoff VE, Coloma PM, et al. Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology. 2014;147(4):784–792.
   PubMed Web of Science ®Google Scholar
• Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol. 2009;7(1):33–47.
   PubMed Web of Science ®Google Scholar
• Miller CS, Dorreen A, Martel M, et al. Risk of gastrointestinal bleeding in patients taking Non-Vitamin K antagonist oral anticoagulants: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(11):1674–1683.
   PubMed Web of Science ®Google Scholar
• Admassie E, Chalmers L, Bereznicki LR. Changes in oral anticoagulant prescribing for stroke prevention in patients with atrial fibrillation. Am J Cardiol. 2017;120(7):1133–1138.
   PubMed Web of Science ®Google Scholar
• Lanas-Gimeno A, Lanas A. Risk of gastrointestinal bleeding during anticoagulant treatment. Expert Opin Drug Saf. 2017;16(6):673–685.
   PubMed Web of Science ®Google Scholar
• Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2015;47:a1–a46.
   PubMed Web of Science ®Google Scholar
• Bisschops R, Areia M, Coron E, et al. Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2016;48:843–864.
   PubMed Web of Science ®Google Scholar
• Kaminski MF, Thomas-Gibson S, Bugajski M, et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative. Endoscopy. 2017;49:1–20.
   PubMed Web of Science ®Google Scholar
• Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology. 2004;62(7):1187–1189.
   PubMed Web of Science ®Google Scholar
• Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J. 2006;27(22):2667–2674.
   PubMed Web of Science ®Google Scholar
• Garcia-Rodriguez LA, Cea-Soriano L, Martin-Merino E, et al. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ. 2011; 343:d4094. DOI 10.1136/bmj.d4094.
   PubMedGoogle Scholar
• Soriano L, Bueno H, Lanas A, et al. Cardiovascular and upper gastrointestinal bleeding consequences of low dose acetylsalicylic acid discontinuation. Thromb Haemost. 2013;110(12):1298–1304.
   PubMedGoogle Scholar
• Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152(1):1–9.
   PubMed Web of Science ®Google Scholar
• Derogar M, Sandblom G, Lundell L, et al. Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol. 2013;11(1):38–42.
   PubMed Web of Science ®Google Scholar
• Kim SY, Hyun JJ, Suh SJ, et al. Risk of vascular thrombotic events following discontinuation of antithrombotics after peptic ulcer bleeding. J Clin Gastroenterol. 2016;50:e40–e44.
   PubMed Web of Science ®Google Scholar
• Staerk L, Lip GY, Olesen JB, et al. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ. 2015;351:h5876.
   PubMed Web of Science ®Google Scholar
• Qureshi W, Mittal C, Patsias I, et al. Restarting anticoagulation and outcomes after major gastrointestinal bleeding in atrial fibrillation. Am J Cardiol. 2014;113(4):662–668.
   PubMed Web of Science ®Google Scholar
• Lip GYH, Collet JP, Caterina R, et al. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 2017;19:1757–1758.
   PubMed Web of Science ®Google Scholar
• Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e326S–e350S.
   PubMed Web of Science ®Google Scholar
• Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172(19):1484–1491.
   PubMedGoogle Scholar
• Lee JK, Kang HW, Kim SG, et al. Risks related with withholding and resuming anticoagulation in patients with non-variceal upper gastrointestinal bleeding while on warfarin therapy. Int J Clin Pract. 2012;66(1):64–68.
   PubMed Web of Science ®Google Scholar
• Keiffer MR. Utilization of clinical practice guidelines: barriers and facilitators. Nurs Clin North Am. 2015; 50(2):327–345.
   PubMed Web of Science ®Google Scholar
• Vaucher C, Bovet E, Bengough T, et al. Meeting physicians’ needs: a bottom-up approach for improving the implementation of medical knowledge into practice. Health Res Policy Sys. 2016;14(1):49.
   PubMedGoogle Scholar
• Lobach DF, Hammond WE. Computerized decision support based on a clinical practice guideline improves compliance with care standars. Am J Med. 1997;102(1):89–98.
   PubMed Web of Science ®Google Scholar
• Goud R, van Engen-Verheul M, de Keizer NF, et al. The effect of computerized decision support on barriers to guideline implementation: a qualitative study in outpatient cardiac rehabilitation. Int J Med Inform. 2010;79(6):430–437.
   PubMed Web of Science ®Google Scholar
• Navarro-Juan M, Carbonell-Torregrosa MA, Palazon-Bru A, et al. Nonadherence to guidelines for prescribing antiplatet/anticoagulant therapy in patients with atrial fibrillation. FAMPRJ. 2016;33(3):290–295.
   Web of Science ®Google Scholar
• Lip GY, Laroche C, Dan GA, et al. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace. 2014;16(3):308–319.
   PubMed Web of Science ®Google Scholar
• Burger W, Chemnitius JM, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med. 2005;257(5):399–414.
   PubMed Web of Science ®Google Scholar